Exchange Traded Concepts’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $915K | Sell |
2,806
-909
| -24% | -$296K | 0.01% | 701 |
|
|
2025
Q1 | $1M | Sell |
3,715
-118
| -3% | -$31.9K | 0.02% | 557 |
|
|
2024
Q4 | $902K | Buy |
3,833
+265
| +7% | +$62.4K | 0.02% | 598 |
|
|
2024
Q3 | $981K | Buy |
3,568
+136
| +4% | +$37.4K | 0.02% | 515 |
|
|
2024
Q2 | $834K | Sell |
3,432
-356
| -9% | -$86.5K | 0.02% | 500 |
|
|
2024
Q1 | $566K | Sell |
3,788
-1,625
| -30% | -$243K | 0.01% | 639 |
|
|
2023
Q4 | $1.04M | Buy |
5,413
+2,040
| +60% | +$390K | 0.03% | 397 |
|
|
2023
Q3 | $597K | Sell |
3,373
-4,860
| -59% | -$861K | 0.02% | 520 |
|
|
2023
Q2 | $1.56M | Sell |
8,233
-13,035
| -61% | -$2.48M | 0.04% | 311 |
|
|
2023
Q1 | $4.26M | Buy |
21,268
+13,900
| +189% | +$2.78M | 0.12% | 133 |
|
|
2022
Q4 | $1.75M | Sell |
7,368
-724
| -9% | -$172K | 0.05% | 201 |
|
|
2022
Q3 | $1.62M | Sell |
8,092
-5,161
| -39% | -$1.03M | 0.05% | 174 |
|
|
2022
Q2 | $1.93M | Sell |
13,253
-279
| -2% | -$40.7K | 0.06% | 164 |
|
|
2022
Q1 | $2.21M | Buy |
13,532
+4,618
| +52% | +$754K | 0.04% | 210 |
|
|
2021
Q4 | $1.51M | Sell |
8,914
-177
| -2% | -$30K | 0.03% | 278 |
|
|
2021
Q3 | $1.72M | Sell |
9,091
-1,997
| -18% | -$377K | 0.04% | 241 |
|
|
2021
Q2 | $1.88M | Buy |
11,088
+344
| +3% | +$58.3K | 0.06% | 226 |
|
|
2021
Q1 | $1.52M | Buy |
10,744
+3,368
| +46% | +$476K | 0.06% | 228 |
|
|
2020
Q4 | $959K | Buy |
7,376
+4,629
| +169% | +$602K | 0.04% | 234 |
|
|
2020
Q3 | $400K | Buy |
2,747
+1,272
| +86% | +$185K | 0.02% | 348 |
|
|
2020
Q2 | $218K | Buy |
1,475
+768
| +109% | +$114K | 0.04% | 458 |
|
|
2020
Q1 | $77K | Buy |
707
+323
| +84% | +$35.2K | 0.04% | 280 |
|
|
2019
Q4 | $44K | Buy |
+384
| New | +$44K | 0.01% | 283 |
|